Healthcare entity
Every one of those 1 sits in a single category, regulation. B. Braun Medical Inc. is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. The tracked stories average 2 original sources each. Lot J4H077 appears in 1 tracked Healthcare story from August 21, 2026.
Last mentioned: Aug 21, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, regulation. B. Braun Medical Inc. is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. The tracked stories average 2 original sources each. Lot J4H077 appears in 1 tracked Healthcare story from August 21, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 5 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Lot J4H077. Shared-story counts are live from our verified record — not editorial picks.
Recalled lot expiration date
Lot J4H077 was labeled with an expiration date of November 30, 2026, meaning unexpired units could still be in circulation if not quarantined.
Recall posted on FDA website
The FDA website posts B. Braun's company announcement alerting healthcare providers and the public to the recall.
Voluntary recall issued
B. Braun Medical Inc. voluntarily recalls lot J4H077 after identifying particulate matter, including cellulose cotton fibers, wood fiber, and polystyrene.
Distribution window ends
The recalled lot J4H077 completes its distribution period after approximately one month.
Distribution of recalled lot begins
B. Braun distributes Excel Lactated Ringers Injection, 1,000 mL lot J4H077 to hospital-level facilities nationally and in Canada.
Hospitals and health systems must quickly locate and quarantine a recalled lot of B. Braun's Excel Lactated Ringers Injection after particulate contamination raised risks of pulmonary emboli, vessel occlusion, and phlebitis. The recall only covers one lot, but expiration extends to November 2026, so stock may still be present.
Lot J4H077 is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
